PL440293A1 - Zastosowanie tlenku carlina do profilaktyki zakażeń wirusem SARS-CoV-2 oraz leczenia choroby COVID-19 - Google Patents
Zastosowanie tlenku carlina do profilaktyki zakażeń wirusem SARS-CoV-2 oraz leczenia choroby COVID-19Info
- Publication number
- PL440293A1 PL440293A1 PL440293A PL44029322A PL440293A1 PL 440293 A1 PL440293 A1 PL 440293A1 PL 440293 A PL440293 A PL 440293A PL 44029322 A PL44029322 A PL 44029322A PL 440293 A1 PL440293 A1 PL 440293A1
- Authority
- PL
- Poland
- Prior art keywords
- oxide
- covid
- treatment
- carlina
- disease
- Prior art date
Links
- 208000025721 COVID-19 Diseases 0.000 title abstract 2
- 241001678559 COVID-19 virus Species 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000009385 viral infection Effects 0.000 title abstract 2
- ICRHFCVRNWSKQH-UHFFFAOYSA-N Carlina oxide Chemical compound C=1C=CC=CC=1CC#CC1=CC=CO1 ICRHFCVRNWSKQH-UHFFFAOYSA-N 0.000 title 2
- HOWWJRHBQZWPKM-UHFFFAOYSA-N Carlinoxide Natural products C(C#CC1CCCO1)c2ccccc2 HOWWJRHBQZWPKM-UHFFFAOYSA-N 0.000 abstract 4
- 241000207965 Acanthaceae Species 0.000 abstract 1
- 241000132043 Carlina Species 0.000 abstract 1
- 240000000614 Carlina acanthifolia Species 0.000 abstract 1
- 240000001789 Carlina acaulis Species 0.000 abstract 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 abstract 1
- 241000208809 Carthamus Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- YSFNIVKHYKBKHI-SAETXWKOSA-N [(1r,4ar,7s)-7-ethenyl-1,4a,7-trimethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-1-yl]methanol Chemical compound OC[C@]1(C)CCC[C@@]2(C)C3=CC[C@@](C=C)(C)CC3CCC21 YSFNIVKHYKBKHI-SAETXWKOSA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- YSFNIVKHYKBKHI-UHFFFAOYSA-N ent-isopimar-9(11)-15-diene-19-ol Natural products OCC1(C)CCCC2(C)C3=CCC(C=C)(C)CC3CCC21 YSFNIVKHYKBKHI-UHFFFAOYSA-N 0.000 abstract 1
- 229920001197 polyacetylene Polymers 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Istotą wynalazku jest zastosowanie tlenku carlina - naturalnego poliacetylenu do profilaktyki zakażeń wirusem SARS CoV-2 oraz leczenia choroby COVID-19, korzystnie w postaci ekstraktu. Zastosowany tlenek carlina izolowany jest z korzeni roślin - gatunków z rodzaju Carlina L. (dziewięćsił), Carthamus (krokosz), korzystnie izolowany z korzeni C. acaulis L. lub izolowany z korzeni C. acanthifolia L. (dziewięćsiłu akantolistnego). Zastosowany tlenek carlina korzystnie uzyskiwany jest syntetycznie. Zgłoszenie obejmuje też zastosowanie tlenku carlina jako dodatku do suplementów diety, stosowanych we wspomaganiu leczenia COVID.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL440293A PL245100B1 (pl) | 2022-02-02 | 2022-02-02 | Zastosowanie tlenku carlina do profilaktyki zakażeń wirusem SARS-CoV-2 oraz leczenia choroby COVID-19 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL440293A PL245100B1 (pl) | 2022-02-02 | 2022-02-02 | Zastosowanie tlenku carlina do profilaktyki zakażeń wirusem SARS-CoV-2 oraz leczenia choroby COVID-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL440293A1 true PL440293A1 (pl) | 2022-07-25 |
| PL245100B1 PL245100B1 (pl) | 2024-05-13 |
Family
ID=83721649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL440293A PL245100B1 (pl) | 2022-02-02 | 2022-02-02 | Zastosowanie tlenku carlina do profilaktyki zakażeń wirusem SARS-CoV-2 oraz leczenia choroby COVID-19 |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL245100B1 (pl) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL444710A1 (pl) * | 2023-04-29 | 2024-11-04 | Uniwersytet Medyczny W Lublinie | Kompozycja farmaceutyczna i jej zastosowanie w profilaktyce i leczeniu zakażenia górnych dróg oddechowych wywołanego wirusem SARS-CoV-2 oraz sposób wytwarzania preparatów stosowanych w profilaktyce i leczeniu infekcji wirusem SARS-CoV-2 |
-
2022
- 2022-02-02 PL PL440293A patent/PL245100B1/pl unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL444710A1 (pl) * | 2023-04-29 | 2024-11-04 | Uniwersytet Medyczny W Lublinie | Kompozycja farmaceutyczna i jej zastosowanie w profilaktyce i leczeniu zakażenia górnych dróg oddechowych wywołanego wirusem SARS-CoV-2 oraz sposób wytwarzania preparatów stosowanych w profilaktyce i leczeniu infekcji wirusem SARS-CoV-2 |
Also Published As
| Publication number | Publication date |
|---|---|
| PL245100B1 (pl) | 2024-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
| PH12022550438A1 (en) | N4-hydroxycytidine and derivatives and anti-viral uses related thereto | |
| MX2023000411A (es) | Vacuna combinada de sars-cov-2 e influenza. | |
| SA521430813B1 (ar) | لقاح وحدات فرعية لعلاج عدوى الجهاز التنفسي أو الوقاية منها | |
| BR112019007420A2 (pt) | composto, uso de um composto, composição cosmética ou farmacêutica, e, método cosmético não terapêutico de tratamento e/ou cuidado da pele, do cabelo, das unhas e/ou das membranas mucosas | |
| BR112022005883A2 (pt) | Composições para tratamento bucal anticárie isentas de fluoreto | |
| BR112022004397A2 (pt) | Composições para tratamento bucal que compreendem beta ácidos de lúpulo e aminoácidos | |
| PL440293A1 (pl) | Zastosowanie tlenku carlina do profilaktyki zakażeń wirusem SARS-CoV-2 oraz leczenia choroby COVID-19 | |
| MX2023006146A (es) | Composiciones bacterianas diseñadas para tratar la enfermedad de injerto contra huésped. | |
| BR112022024226A2 (pt) | Métodos para tratar ou prevenir uma infecção súbita por coronavírus da síndrome respiratória aguda, para tratar uma síndrome do desconforto respiratório agudo e para tratar uma disfunção imunológica ou condição hiperinflamatória em um sujeito mamífero, composição ou kit antiviral para uso em seres humanos, e, composição farmacêutica ou kit para uso na prevenção ou tratamento da síndrome respiratória aguda em um sujeito mamífero | |
| CO2023000070A2 (es) | Moléculas de anticuerpo contra el virus bk | |
| BR112022020441A2 (pt) | Composições compreendendo nanopartículas, método de fabricação e usos das mesmas | |
| EA202091690A1 (ru) | Иммуногенная композиция, содержащая стафилококковые антигены | |
| MX2022012165A (es) | Interaccion de proteinas de sars-cov-2 con mecanismos moleculares y celulares de celulas huespedes y formulaciones para tratar covid-19. | |
| BR112023000650A2 (pt) | Vírus vaccinia recombinante | |
| FR3063905B1 (fr) | Utilisation de copaifera en cosmetique et en dermatologie | |
| JOP20240233A1 (ar) | بروتينات cd24 الطافرة واستخداماتها للوقاية من السرطان وعلاجه | |
| BR112023003135A2 (pt) | Óleo de silybum marianum (l.) gaertn. no reforço da função de barreira da pele | |
| PH12022552300A1 (en) | Cpg-adjuvanted sars-cov-2 virus vaccine | |
| PL445779A1 (pl) | Zastosowanie olejku eterycznego z korzeni dziewięćsiłu pospolitego (Carlina vulgaris L.) do profilaktyki zakażeń wirusem SARS-CoV-2 oraz leczenia choroby COVID-19 | |
| MX2023002109A (es) | Inhibidores virales. | |
| MX2024005962A (es) | Composiciones de proteínas de fusión inmunogénicas y métodos de uso de estas | |
| DE60216118D1 (de) | Sesquiterpenoid-derivate mit adipozytendifferenzierungshemmender wirkung | |
| MX2023006076A (es) | Derivados de cannabinoides y su uso en el tratamiento de la inflamación y/o el dolor y/o la obesidad. | |
| CL2021001889A1 (es) | Metodos para purificar el extracto de un alergeno |